Filing a Concerta lawsuit may be an option for individuals who experienced suicidal ideation or behavior while using this medication. Recently, some reports have suggested that certain ADHD drugs, including Concerta, Ritalin, and Adderall XR, could be associated with these serious side effects.
The nationwide law firm of Bernstein Liebhard LLP provides free, no-obligation legal reviews to those who have been harmed by prescription drugs, including Concerta. If you or a loved one experienced suicidal thought or behavior while using Concerta, Ritalin or Adderall XR, please call (888) 994-5118 to discuss your case with one of our attorneys today.
Concerta is a long-acting form of methylphenidate that is indicated to treat ADHD in adults and children. The medication is marketed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, and was initially approved by the U.S. Food & Drug Administration (FDA) in 2000. Methylphenidate is sold under a number of other brand names, including Ritalin.
FDA Concerta Label Update
In 2005, the FDA posted a statement on its website announcing its intention to add stronger label warnings regarding psychiatric side effects to all methylphenidate-containing medications, including Concerta and Ritalin. The FDA acted after a review found that Concerta had been associated with an unexpectedly high number of reports of psychiatric reactions, including suicidal thoughts, hallucinations and violent behavior. A subsequent review of all methylphenidate products found similar reports. The review raised concerns that the drugs’ labels were downplaying the seriousness of these problems, as the current wording suggested that these side effects only occurred in patients with pre-existing psychiatric disorders.
The FDA also said it was investigating whether or not similar psychiatric behaviors are seen with other ADHD treatments, such as Adderall and Strattera.
In 2015, Health Canada, that country’s counterpart to the FDA, announced that stronger, clearer warnings regarding the risk of suicidal thoughts and behaviors would be added to the labels of Concerta and other drugs used to treat ADHD. According to the regulator, the label modifications were prompted by reports of suicidal behavior, including some completed suicides, in patients taking the medications. Other drugs named in the Health Canada notification included:
When pharmaceutical companies fail to warn doctors and patients about the risks associated with a medication, victims of those side effects might be entitled to compensation for the harm that was done. If it can be shown that the suicide warnings included on the Concerta label were inadequate, patients who experienced suicidal thoughts and behaviors while using the medication may be entitled to compensation for related medical bills, lost wages, emotional distress, pain and suffering and more.
You may be concerned about the costs associated with filing a lawsuit. However, there is no need to worry, as Bernstein Liebhard LLP represents Concerta plaintiffs on a contingency basis. This means that our clients are not required to pay any legal fees or attorney costs unless the Firm successfully recovers financial compensation on their behalf. If your lawsuit does not result in a verdict or settlement in your favor, you will not be expected to pay a single penny of legal fees. If our attorneys are able to recover financial compensation in your case, our fees will be taken from a portion of your recovery.
Our legal staff is available now to provide free, no-obligation case reviews to those interested in pursuing a Concerta lawsuit for suicidal thoughts and behavior, as well those who experienced similar side effects while taking Ritalin or Adderall XR. To learn more, please call (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.